iShares Trust - iShares LifePath Target Date 2025 ETF's EBIT is $-1.9M, above the sector sector average of $-69M.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026
As of the most recent data (March 2026), ITDA shows a EBIT of $-1.9M. That compares with $20M in the prior-year period — down 109.5% year over year. That is above the sector sector average of $-69M. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ITDA's EBIT is now $-1.9M (was $20M) — a 109.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether iShares Trust - iShares LifePath Target Date 2025 ETF is outperforming or lagging.
The its sector sector average EBIT is about $-69M. iShares Trust - iShares LifePath Target Date 2025 ETF is at $-1.9M, which is higher that average. That is roughly 97.2% above the sector mean. Use the comparison chart on this page to see how ITDA stacks up against individual peers as well.
Tracking ITDA's ebit over time shows whether iShares Trust - iShares LifePath Target Date 2025 ETF is scaling, shrinking, or reshaping that part of the business. The current reading is $-1.9M That compares with $20M in the prior-year period — down 109.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this ebit page, Stockcircle has iShares Trust - iShares LifePath Target Date 2025 ETF's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-1.9M) with ownership activity and broader fundamentals.